Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-15-047289

CEO and President acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Butler John P. CEO and President 2015-05-26 Option exercise +50,000 $0.47 $23,500 198,350 D
Derivatives
Butler John P. CEO and President 2015-05-26 Option exercise · Stock Option (Right to Buy) −50,000 0 D
Loading xslF345X03/doc4.xml…